HEXO Corp. (HEXO) Receives Average Recommendation of “Strong Buy” from Analysts

Shares of HEXO Corp. (NASDAQ:HEXO) have been assigned a consensus broker rating score of 1.17 (Strong Buy) from the six analysts that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a buy recommendation and five have issued a strong buy recommendation on the company.

Analysts have set a 12-month consensus target price of $8.50 for the company and are forecasting that the company will post ($0.04) earnings per share for the current quarter, according to Zacks. Zacks has also given HEXO an industry rank of 60 out of 255 based on the ratings given to its competitors.

HEXO has been the subject of a number of recent analyst reports. Beacon Securities reiterated a “buy” rating on shares of HEXO in a research report on Tuesday, February 19th. CIBC initiated coverage on HEXO in a research report on Tuesday, February 19th. They issued an “outperform” rating and a $7.00 price target for the company. Jefferies Financial Group initiated coverage on HEXO in a research report on Monday, February 25th. They issued an “underperform” rating for the company. Oppenheimer initiated coverage on HEXO in a research report on Tuesday, February 19th. They issued an “outperform” rating and a $7.00 price target for the company. Finally, Seaport Global Securities initiated coverage on HEXO in a research report on Thursday, February 21st. They issued a “buy” rating and a $12.00 price target for the company.



HEXO stock traded up $0.15 during trading hours on Thursday, hitting $6.10. 6,253,000 shares of the stock traded hands, compared to its average volume of 1,849,864. HEXO has a one year low of $2.64 and a one year high of $7.17.

HEXO Company Profile

HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.

Read More: Investing in Dividend Stocks

Get a free copy of the Zacks research report on HEXO (HEXO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HEXO (NASDAQ:HEXO)

Receive News & Ratings for HEXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HEXO and related companies with MarketBeat.com's FREE daily email newsletter.